Niraparib product-specific bioequivalence guidance - Scientific guideline

Semaglutide tablet 1.5, 4, 9, 25 and 50 mg product-specific bioequivalence guidance.

Keywords: Bioequivalence, generics, Niraparib

Open consultation

Niraparib hard capsules 100 mg and film-coated tablets 100 mg product-specific bioequivalence guidance

Draft: consultation open Consultation dates: 26/10/2026 to 31/01/2027 Reference Number: EMA/200148/2026 Summary:

Comments should be provided using this EUSurvey form. For any technical issues, please contact the EUSurvey Support.